Keith DiMarino
Thorofare, New Jersey,United States
Find Keith DiMarino's Email
Find Keith DiMarino’s PhoneKeith DiMarino's Overview
Keith DiMarino is a seasoned executive in the biotechnology and pharmaceutical industry with over two decades of experience in corporate strategy, business development, commercial operations, and alliance management. He has a strong background in cell and gene therapy, rare diseases, and oncology. Keith is known for his ability to build and lead high-performing teams, drive strategic growth initiatives, and forge impactful partnerships. He currently serves as the Chief Business Officer at Cellares, a company focused on revolutionizing cell therapy manufacturing. His expertise lies in translating scientific innovation into commercial success and expanding access to novel therapeutics.
Professional Summary
Keith DiMarino's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Notable Achievements
Chief Business Officer at Cellares
Leads corporate strategy, business development, and commercialization efforts for Cellares, aiming to enable industrial-scale cell therapy manufacturing through their innovative Cell Shuttle platform.
Strategic Leadership in Gene Editing
Previously served as Senior Vice President, Head of Company & Corporate Development at Prime Medicine, contributing significantly to the company's strategy and growth in the pioneering field of prime editing technology.
Extensive Biopharmaceutical Business Development Experience
Held significant business development and corporate strategy roles at companies like Bioverativ (a Sanofi company) and Biogen, where he was involved in numerous strategic transactions, including M&A, licensing, and collaborations across various therapeutic areas.
Advancing Therapies for Rare Diseases
Contributed to the development and commercialization of therapies for rare diseases during his tenure at Bioverativ and Biogen, demonstrating a commitment to addressing unmet medical needs.
Educational Background
BS, Entrepreneurial Management
The Wharton School - Year 1996
Haverford School
Buying Intent Signals for Keith DiMarino
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Company Overview
GenVaultGenVault, Inc. specialized in developing and commercializing solutions for room-temperature biological sample storage and management, particularly for DNA and RNA. Their technology aimed to improve sample integrity, reduce storage costs, and simplify sample handling for research, clinical, and forensic applications. GenVault was acquired by Integromics in 2011, and Integromics was subsequently acquired by QIAGEN in 2013, with GenVault's technologies becoming part of QIAGEN's portfolio.
Highperformr's free tools for company research
Find contact info
Get verified emails, phone numbers, and LinkedIn profile details
Find similar contacts
Discover contacts with similar roles, seniority, or companies
Perform deep contact research
Uncover insights like skills, work history, social links, and more
Discover, research and enrich contacts with Highperformr — Smarter, Faster
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
- Track signals like job change, promotion, and LinkedIn activity
- Enrich contacts with verified email, phone, and social data instantly
- Automate enrichment and updates with powerful workflows
- Sync enriched contact info directly into your CRM and tools
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.